nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Vismodegib—SMO—meningioma	0.144	1	CrCbGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTSL—meningioma	0.00216	0.0026	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—meningioma	0.00211	0.00253	CbGpPWpGaD
Sulfasalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00208	0.0025	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-4 Signaling Pathway—AKT1—meningioma	0.00208	0.00249	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	0.00207	0.00249	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00207	0.00249	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD34—meningioma	0.00206	0.00247	CbGpPWpGaD
Sulfasalazine—IKBKB—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00205	0.00246	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—AKT1—meningioma	0.00205	0.00246	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—AKT1—meningioma	0.00205	0.00246	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CTSL—meningioma	0.00204	0.00245	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—ERBB2—meningioma	0.00204	0.00245	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AP1B1—meningioma	0.00204	0.00244	CbGpPWpGaD
Sulfasalazine—ACAT1—medulla oblongata—meningioma	0.00203	0.0932	CbGeAlD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—meningioma	0.00202	0.00243	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00201	0.00241	CbGpPWpGaD
Sulfasalazine—PPARG—SREBP signalling—AKT1—meningioma	0.00201	0.00241	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CTSL—meningioma	0.00196	0.00235	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—meningioma	0.00195	0.00234	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—AKT1—meningioma	0.00195	0.00234	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—ERBB2—meningioma	0.00195	0.00234	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—ERBB2—meningioma	0.00194	0.00232	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	0.00193	0.00231	CbGpPWpGaD
Sulfasalazine—CHUK—BCR signaling pathway—AKT1—meningioma	0.00193	0.00231	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—ERBB2—meningioma	0.00193	0.00231	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—ERBB2—meningioma	0.00192	0.0023	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HES1—meningioma	0.00191	0.0023	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—meningioma	0.00191	0.00229	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00189	0.00227	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00189	0.00226	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—AKT1—meningioma	0.00189	0.00226	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AP1B1—meningioma	0.00188	0.00226	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—PTEN—meningioma	0.00185	0.00222	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AP1B1—meningioma	0.00185	0.00221	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—PDGFB—meningioma	0.00184	0.0022	CbGpPWpGaD
Sulfasalazine—ACAT1—spinal cord—meningioma	0.00181	0.0831	CbGeAlD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00181	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—ERBB2—meningioma	0.00181	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—ERBB2—meningioma	0.00181	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—ERBB2—meningioma	0.00179	0.00215	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00177	0.00213	CbGpPWpGaD
Sulfasalazine—IKBKB—mTOR signaling pathway—AKT1—meningioma	0.00177	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—meningioma	0.00177	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—AKT1—meningioma	0.00177	0.00212	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—PTEN—meningioma	0.00177	0.00212	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—ERBB2—meningioma	0.00177	0.00212	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—AKT1—meningioma	0.00176	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	0.00175	0.0021	CbGpPWpGaD
Sulfasalazine—IKBKB—BCR signaling pathway—AKT1—meningioma	0.00175	0.0021	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00175	0.0021	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—PTEN—meningioma	0.00174	0.00209	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—meningioma	0.00173	0.00207	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00172	0.00206	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—AKT1—meningioma	0.00171	0.00205	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—TSHB—meningioma	0.0017	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.0017	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—ERBB2—meningioma	0.00167	0.002	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PDGFB—meningioma	0.00166	0.002	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—PTEN—meningioma	0.00166	0.00199	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—PTEN—meningioma	0.00165	0.00198	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—PTEN—meningioma	0.00164	0.00197	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00164	0.00196	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PDGFB—meningioma	0.00164	0.00196	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—PTEN—meningioma	0.00164	0.00196	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALAD—meningioma	0.00164	0.00196	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—meningioma	0.00162	0.00195	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00161	0.00193	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00161	0.00193	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—AKT1—meningioma	0.00161	0.00193	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—AKT1—meningioma	0.0016	0.00192	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.0016	0.00192	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.00158	0.0019	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00154	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—PTEN—meningioma	0.00154	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—PTEN—meningioma	0.00154	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—PTEN—meningioma	0.00153	0.00183	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—AKT1—meningioma	0.00152	0.00183	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—AKT1—meningioma	0.00152	0.00182	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—ERBB2—meningioma	0.00152	0.00182	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—PTEN—meningioma	0.00151	0.00182	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—PTEN—meningioma	0.00151	0.00181	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—PTEN—meningioma	0.00151	0.00181	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—AKT1—meningioma	0.0015	0.0018	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—PTEN—meningioma	0.00148	0.00178	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HES1—meningioma	0.00148	0.00177	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00147	0.00176	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00146	0.00175	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00146	0.00175	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—AKT1—meningioma	0.00146	0.00175	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00145	0.00174	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00144	0.00172	CbGpPWpGaD
Sulfasalazine—ACAT1—cerebellum—meningioma	0.00143	0.0659	CbGeAlD
Sulfasalazine—CHUK—B Cell Activation—PTEN—meningioma	0.00143	0.00171	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—AKT1—meningioma	0.00142	0.00171	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.0014	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—AKT1—meningioma	0.00139	0.00167	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—AKT1—meningioma	0.00138	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00138	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—AKT1—meningioma	0.00138	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD34—meningioma	0.00138	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00136	0.00164	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—AKT1—meningioma	0.00136	0.00163	CbGpPWpGaD
Sulfasalazine—SLC46A1—spinal cord—meningioma	0.00135	0.0619	CbGeAlD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.00135	0.00162	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTSL—meningioma	0.00131	0.00157	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.0013	0.00156	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—PTEN—meningioma	0.00129	0.00155	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALAD—meningioma	0.00129	0.00154	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00125	0.0015	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD34—meningioma	0.00125	0.0015	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—ERBB2—meningioma	0.00123	0.00148	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—meningioma	0.00119	0.00143	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALAD—meningioma	0.00119	0.00143	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTSL—meningioma	0.00119	0.00143	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PTEN—meningioma	0.00118	0.00142	CbGpPWpGaD
Sulfasalazine—ACAT1—brain—meningioma	0.00117	0.0535	CbGeAlD
Sulfasalazine—PTGS1—Metabolism—ALAD—meningioma	0.00115	0.00137	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CST3—meningioma	0.00112	0.00134	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—ERBB2—meningioma	0.00112	0.00134	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AP1B1—meningioma	0.00111	0.00134	CbGpPWpGaD
Sulfasalazine—SLC7A11—spinal cord—meningioma	0.00111	0.051	CbGeAlD
Sulfasalazine—PPARG—Gene Expression—PGR—meningioma	0.0011	0.00132	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—ERBB2—meningioma	0.0011	0.00132	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00108	0.00129	CbGpPWpGaD
Sulfasalazine—SLC46A1—cerebellum—meningioma	0.00107	0.0491	CbGeAlD
Sulfasalazine—CHUK—cerebellum—meningioma	0.00107	0.0491	CbGeAlD
Sulfasalazine—CHUK—Signaling by SCF-KIT—AKT1—meningioma	0.00106	0.00128	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—TSHB—meningioma	0.00105	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—PTEN—meningioma	0.00105	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PDGFB—meningioma	0.00105	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—AKT1—meningioma	0.00105	0.00126	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00104	0.00125	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—AKT1—meningioma	0.00102	0.00122	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—meningioma	0.00101	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—meningioma	0.00101	0.00121	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00101	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PDGFB—meningioma	0.00101	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—AKT1—meningioma	0.001	0.0012	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—meningioma	0.000994	0.00119	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000989	0.00119	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.000976	0.00117	CbGpPWpGaD
Sulfasalazine—TBXAS1—brain—meningioma	0.000974	0.0447	CbGeAlD
Sulfasalazine—SLC7A11—Hemostasis—TP53—meningioma	0.000973	0.00117	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—AKT1—meningioma	0.000957	0.00115	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—AKT1—meningioma	0.000953	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PTEN—meningioma	0.000951	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PDGFB—meningioma	0.000949	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—AKT1—meningioma	0.000949	0.00114	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—AKT1—meningioma	0.000948	0.00114	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—AKT1—meningioma	0.000943	0.00113	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTEN—meningioma	0.000936	0.00112	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00093	0.00111	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PDGFB—meningioma	0.000912	0.00109	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALAD—meningioma	0.000909	0.00109	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTEN—meningioma	0.000897	0.00108	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—AKT1—meningioma	0.000888	0.00106	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000888	0.00106	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—AKT1—meningioma	0.000888	0.00106	CbGpPWpGaD
Sulfasalazine—SLC7A11—cerebellum—meningioma	0.00088	0.0404	CbGeAlD
Sulfasalazine—CHUK—Signaling by EGFR—AKT1—meningioma	0.00088	0.00105	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—AKT1—meningioma	0.000872	0.00105	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—AKT1—meningioma	0.000872	0.00105	CbGpPWpGaD
Sulfasalazine—SLC46A1—brain—meningioma	0.000868	0.0399	CbGeAlD
Sulfasalazine—CHUK—brain—meningioma	0.000868	0.0399	CbGeAlD
Sulfasalazine—CHUK—Signaling by PDGF—AKT1—meningioma	0.000868	0.00104	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—meningioma	0.000861	0.00103	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000858	0.00103	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALAD—meningioma	0.000854	0.00102	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—ERBB2—meningioma	0.000846	0.00101	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000843	0.00101	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—meningioma	0.000839	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000835	0.001	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TSHB—meningioma	0.00083	0.000995	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TSHB—meningioma	0.000827	0.000992	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—meningioma	0.000821	0.000985	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—meningioma	0.000821	0.000985	CbGpPWpGaD
Sulfasalazine—PLA2G1B—brain—meningioma	0.000816	0.0375	CbGeAlD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000805	0.000965	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000786	0.000943	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTEN—meningioma	0.000784	0.00094	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TSHB—meningioma	0.000768	0.000921	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TSHB—meningioma	0.00075	0.000899	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—meningioma	0.000745	0.000893	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TSHB—meningioma	0.000738	0.000885	CbGpPWpGaD
Sulfasalazine—IKBKB—cerebellum—meningioma	0.000727	0.0334	CbGeAlD
Sulfasalazine—SLC7A11—brain—meningioma	0.000715	0.0328	CbGeAlD
Sulfasalazine—CHUK—Signaling Pathways—SMO—meningioma	0.000703	0.000843	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ERBB2—meningioma	0.000702	0.000841	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—meningioma	0.000682	0.000818	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PGR—meningioma	0.000674	0.000808	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ERBB2—meningioma	0.000674	0.000808	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CST3—meningioma	0.000663	0.000794	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HES1—meningioma	0.000658	0.000789	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTEN—meningioma	0.000654	0.000784	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000645	0.000773	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SMO—meningioma	0.000638	0.000765	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ERBB2—meningioma	0.000636	0.000763	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PGR—meningioma	0.000611	0.000733	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ERBB2—meningioma	0.000611	0.000733	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PDGFB—meningioma	0.00061	0.000731	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—meningioma	0.000605	0.000725	CbGpPWpGaD
Sulfasalazine—ALOX5—cerebellum—meningioma	0.000602	0.0277	CbGeAlD
Sulfasalazine—CHUK—Innate Immune System—PTEN—meningioma	0.000598	0.000717	CbGpPWpGaD
Sulfasalazine—IKBKB—brain—meningioma	0.00059	0.0271	CbGeAlD
Sulfasalazine—PTGS2—Metabolism—TSHB—meningioma	0.000586	0.000703	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000586	0.000702	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PTEN—meningioma	0.000575	0.000689	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PDGFB—meningioma	0.000563	0.000675	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PDGFB—meningioma	0.000553	0.000663	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TSHB—meningioma	0.00055	0.00066	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—meningioma	0.000548	0.000657	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PTEN—meningioma	0.000543	0.000651	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—meningioma	0.000539	0.000647	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PTEN—meningioma	0.000521	0.000625	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—meningioma	0.000517	0.00062	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000508	0.000609	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000495	0.000593	CbGpPWpGaD
Sulfasalazine—ALOX5—brain—meningioma	0.000489	0.0225	CbGeAlD
Sulfasalazine—ALOX5—Metabolism—PTEN—meningioma	0.000464	0.000556	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HES1—meningioma	0.000461	0.000553	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—meningioma	0.000452	0.000542	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000452	0.000541	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HES1—meningioma	0.000418	0.000501	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—meningioma	0.000416	0.000499	CbGpPWpGaD
Sulfasalazine—ABCG2—medulla oblongata—meningioma	0.00041	0.0188	CbGeAlD
Sulfasalazine—CHUK—Immune System—ERBB2—meningioma	0.000409	0.00049	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PDGFB—meningioma	0.000394	0.000473	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HES1—meningioma	0.00039	0.000468	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ERBB2—meningioma	0.000377	0.000452	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—meningioma	0.000377	0.000452	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERBB2—meningioma	0.000371	0.000444	CbGpPWpGaD
Sulfasalazine—PPARG—brain—meningioma	0.000367	0.0169	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—meningioma	0.000365	0.0168	CbGeAlD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000358	0.00043	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PDGFB—meningioma	0.000357	0.000429	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—meningioma	0.000349	0.000418	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—meningioma	0.000345	0.000413	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PDGFB—meningioma	0.000333	0.0004	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—meningioma	0.000331	0.000397	CbGpPWpGaD
Sulfasalazine—PTGS2—medulla oblongata—meningioma	0.000327	0.015	CbGeAlD
Sulfasalazine—CHUK—Disease—PTEN—meningioma	0.000322	0.000386	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—meningioma	0.000316	0.000379	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—meningioma	0.000313	0.000375	CbGpPWpGaD
Sulfasalazine—PTGS1—spinal cord—meningioma	0.000305	0.014	CbGeAlD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—meningioma	0.0003	0.00036	CbGpPWpGaD
Sulfasalazine—PTGS2—spinal cord—meningioma	0.000291	0.0134	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—meningioma	0.00029	0.0133	CbGeAlD
Sulfasalazine—PPARG—Metabolism—PTEN—meningioma	0.000287	0.000344	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—meningioma	0.000267	0.00032	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB2—meningioma	0.000264	0.000317	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB2—meningioma	0.00024	0.000287	CbGpPWpGaD
Sulfasalazine—ABCG2—brain—meningioma	0.000235	0.0108	CbGeAlD
Sulfasalazine—PTGS2—cerebellum—meningioma	0.000231	0.0106	CbGeAlD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—meningioma	0.000226	0.000271	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—meningioma	0.000225	0.00027	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB2—meningioma	0.000224	0.000268	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—meningioma	0.000213	0.000255	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—meningioma	0.000209	0.000251	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—meningioma	0.000204	0.000245	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—meningioma	0.000201	0.000241	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—meningioma	0.000201	0.000241	CbGpPWpGaD
Sulfasalazine—PTGS1—brain—meningioma	0.000196	0.00902	CbGeAlD
Sulfasalazine—PTGS2—Disease—PTEN—meningioma	0.000191	0.000229	CbGpPWpGaD
Sulfasalazine—PTGS2—brain—meningioma	0.000188	0.00862	CbGeAlD
Sulfasalazine—CHUK—Disease—AKT1—meningioma	0.000185	0.000222	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—meningioma	0.000182	0.000218	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—meningioma	0.000165	0.000198	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—meningioma	0.00016	0.000191	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—meningioma	0.000154	0.000184	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—meningioma	0.00015	0.00018	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—meningioma	0.000139	0.000167	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—meningioma	0.00013	0.000156	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—meningioma	0.00013	0.000156	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—meningioma	0.000121	0.000145	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—meningioma	0.000118	0.000141	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—meningioma	0.000116	0.000139	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—meningioma	0.00011	0.000132	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—meningioma	9.2e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—meningioma	8.64e-05	0.000104	CbGpPWpGaD
